News

NPR: Kentucky backs away from plan to fund opioid treatment research with settlement money

Fifty billion dollars is on its way to state and local governments over the coming years. The pool of funding comes from multiple legal settlements with pharmaceutical companies that profited from manufacturing or selling opioid painkillers. As that money continues to be dispersed, officials are trying to figure out how to spend it best to help communities devastated by the deadly opioid epidemic.

Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment

Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans

THE INTERCEPT: CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY

A provision in the annual defense bill would have the Pentagon run clinical trials for members of the military with post-traumatic stress disorder.

Marijuana Moment: Veteran Access To Psychedelics Requires Balance Of Speed And Caution, Says Panel With VA And Former CDC Officials

Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.

Pharmacy Times: Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States

Pharmacy Times interviewed Marcus Capone and Amber Capone, the co-founders of Veterans Exploring Treatment Solutions (VETS), on the current opportunities available for US veterans to seek psychedelic-assisted therapies for post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBIs).